Use of Anaferon (Pediatric Formulation) for Prophylaxis of Acute Respiratory Viral Infections in Preschool Children

Anaferon (pediatric formulation) reduces the incidence of acute respiratory viral infections in sickly children and children with bronchial asthma and has a positive effect on the course of asthma. The preparation produces an immunomodulating effect (increases initially low IFN-γ levels and normaliz...

Full description

Saved in:
Bibliographic Details
Published in:Bulletin of experimental biology and medicine 2009-08, Vol.148 (2), p.266-269
Main Authors: Kondrat'eva, E. I, Matveeva, L. A, Shemyakina, T. A, Logvinenko, Yu. I, Golikova, E. V, Kutuzova, E. B
Format: Article
Language:English
Subjects:
acute respiratory viral infections
anaferon (pediatric formulation)
Antibodies - pharmacology
Antibodies - therapeutic use
Antiviral Agents - pharmacology
Antiviral Agents - therapeutic use
Asthma - drug therapy
Asthma - virology
Biomedical and Life Sciences
Biomedicine
bronchial asthma
Cell Biology
Child
Child, Preschool
Female
Humans
Immune System - drug effects
immunity
Immunoglobulin A - blood
Immunoglobulin A - metabolism
Immunoglobulin G - blood
Immunoglobulin G - metabolism
Interferon-gamma - blood
Interleukin-1beta - blood
Internal Medicine
Laboratory Medicine
Male
Pathology
Respiratory Tract Infections - blood
Respiratory Tract Infections - drug therapy
Respiratory Tract Infections - metabolism
Respiratory Tract Infections - prevention & control
Treatment Outcome
Ultralow Doses
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Anaferon (pediatric formulation) reduces the incidence of acute respiratory viral infections in sickly children and children with bronchial asthma and has a positive effect on the course of asthma. The preparation produces an immunomodulating effect (increases initially low IFN-γ levels and normalizes elevated levels of IL-1β), stimulates synthesis of IgA and IgG, exhibits cytoprotective activity, and improves local immunity of the upper airways in sickly children.
ISSN:0007-4888
1573-8221
DOI:10.1007/s10517-009-0704-y